These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3185853)

  • 1. Tetrahydroaminoacridine, 3,4 diaminopyridine and physostigmine: direct comparison of effects on memory in aged primates.
    Bartus RT; Dean RL
    Neurobiol Aging; 1988; 9(4):351-6. PubMed ID: 3185853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physostigmine, but not 3,4-diaminopyridine, improves radial maze performance in memory-impaired rats.
    Beninger RJ; Wirsching BA; Mallet PE; Jhamandas K; Boegman RJ
    Pharmacol Biochem Behav; 1995 Aug; 51(4):739-46. PubMed ID: 7675853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of efficacy of clonidine on memory in aged cebus monkeys.
    Bartus RT; Dean RL
    Neurobiol Aging; 1988; 9(4):409-11. PubMed ID: 3185860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in neuromuscular transmission in myasthenia gravis by 3,4-diaminopyridine.
    Lundh H; Nilsson O; Rosén I
    Eur Arch Psychiatry Neurol Sci; 1985; 234(6):374-7. PubMed ID: 2992990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physostigmine and recent memory: effects in young and aged nonhuman primates.
    Bartus RT
    Science; 1979 Nov; 206(4422):1087-9. PubMed ID: 227061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Lambert-Eaton syndrome: 3,4-diaminopyridine and pyridostigmine.
    Lundh H; Nilsson O; Rosén I
    Neurology; 1984 Oct; 34(10):1324-30. PubMed ID: 6541305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of DuP 996, with physostigmine, THA and 3,4-DAP on hypoxia-induced amnesia in rats.
    DeNoble VJ; DeNoble KF; Spencer KR; Johnson LC; Cook L; Myers MJ; Scribner RM
    Pharmacol Biochem Behav; 1990 Aug; 36(4):957-61. PubMed ID: 2217526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ineffectiveness of 3,4-diaminopyridine as a therapy for type C botulism.
    Siegel LS; Price JI
    Toxicon; 1987; 25(9):1015-8. PubMed ID: 3433299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of 3,4-diaminopyridine on acetylcholine release at the frog neuromuscular junction.
    Durant NN; Marshall IG
    Eur J Pharmacol; 1980 Oct; 67(2-3):201-8. PubMed ID: 6970132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 3,4-diaminopyridine on the survival of mice injected with botulinum neurotoxin type A, B, E, or F.
    Siegel LS; Johnson-Winegar AD; Sellin LC
    Toxicol Appl Pharmacol; 1986 Jun; 84(2):255-63. PubMed ID: 3715874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective improvement of aged rat short-term spatial memory by 3,4-diaminopyridine.
    Barnes CA; Eppich C; Rao G
    Neurobiol Aging; 1989; 10(4):337-41. PubMed ID: 2554167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of aminopyridines in neurological disorders.
    Sedehizadeh S; Keogh M; Maddison P
    Clin Neuropharmacol; 2012; 35(4):191-200. PubMed ID: 22805230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,4-DAP-evoked transmitter release in hippocampal slices of aged rats with impaired memory.
    Schweizer T; Birthelmer A; Lazaris A; Cassel JC; Jackisch R
    Brain Res Bull; 2003 Dec; 62(2):129-36. PubMed ID: 14638386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive processes in Cebus monkeys (Cebus apella) when solving problem-box tasks.
    Simons D; Holtkötter M
    Folia Primatol (Basel); 1986; 46(3):149-63. PubMed ID: 3804104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in cytosolic free calcium with 1,2,3,4-tetrahydro-5-aminoacridine, 4-aminopyridine and 3,4-diaminopyridine.
    Gibson GE; Manger T
    Biochem Pharmacol; 1988 Nov; 37(21):4191-6. PubMed ID: 2847755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of age-related neurochemical and behavioral deficits by 3,4-diaminopyridine.
    Peterson C; Gibson GE
    Neurobiol Aging; 1983; 4(1):25-30. PubMed ID: 6877484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide effects on memory in aged monkeys.
    Bartus RT; Dean RL; Beer B
    Neurobiol Aging; 1982; 3(1):61-8. PubMed ID: 6124893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct comparison of cognitive facilitation by physostigmine and tetrahydroaminoacridine in two primate models.
    Rupniak NM; Field MJ; Samson NA; Steventon MJ; Iversen SD
    Neurobiol Aging; 1990; 11(6):609-13. PubMed ID: 2280804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel drug of choice in Eaton-Lambert syndrome.
    Lundh H; Nilsson O; Rosén I
    J Neurol Neurosurg Psychiatry; 1983 Jul; 46(7):684-5. PubMed ID: 6310051
    [No Abstract]   [Full Text] [Related]  

  • 20. Memory deficits in aged cebus monkeys and facilitation with central cholinomimetics.
    Bartus RT; Dean RL; Beer B
    Neurobiol Aging; 1980; 1(2):145-52. PubMed ID: 24279938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.